Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6057174 | 1.00 | ACHE (0.32) | ACHESLC2A1ALDH1A1HSD17B10 | |
| SCHEMBL22388371 | 1.00 | ACHE (0.32) | ACHESLC2A1ALDH1A1HSD17B10 | |
| SCHEMBL22388432 | 1.00 | ACHE (0.32) | ACHESLC2A1ALDH1A1HSD17B10 | |
| SCHEMBL4194212 | 1.00 | — | — | |
| SCHEMBL1145601 | 1.00 | — | — | |
| SCHEMBL199625 | 1.00 | — | — | |
| Iodide SCHEMBL28948417 | 0.97 | ACHE (0.31) | ACHE | |
| SCHEMBL722771 | 0.96 | — | — | |
| SCHEMBL721065 | 0.89 | — | — | |
| SCHEMBL12326322 | 0.82 | ALDH1A1 (0.44) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4735711-A | ORGANIC MONOSULFIDE | THE DOW CHEMICAL COMPANY (US) | 1988-04-05 | — | — | US | claimed |
| CN-115668571-A | Electrolyte solution, electrochemical device, lithium ion secondary battery, module, and compound | 大金工业株式会社 | 2023-01-31 | — | — | CN | disclosed |
| EP-3686199-B9 | FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR | CSTONE PHARMACEUTICALS SUZHOU CO LTD (CN) | 2022-12-07 | — | — | EP | disclosed |
| US-10844164-B2 | Oligomer, composition and composite material employing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2020-11-24 | — | — | US | disclosed |
| US-20180171068-A1 | OLIGOMER, COMPOSITION AND COMPOSITE MATERIAL EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2018-06-21 | — | — | US | disclosed |
| US-9650456-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| EP-2825574-B1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORP (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-20150031845-A1 | Process For Producing Polydienes | BRIDGESTONE CORPORATION (JP) | 2015-01-29 | — | — | US | disclosed |
| EP-2825574-A1 | PROCESS FOR PRODUCING POLYDIENES | Bridgestone Corporation (JP) | 2015-01-21 | — | — | EP | disclosed |
| WO-2013138270-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTSONE CORPORATION (JP) | 2013-09-19 | — | — | WO | disclosed |
| US-20050171132-A1 | Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists | XIN ZHILI (US) | 2005-08-04 | — | — | US | disclosed |
| US-20050171131-A1 | Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists | KOSOGOF CHRISTI (US) | 2005-08-04 | — | — | US | disclosed |
| WO-2005030734-A1 | DIAMINOPYRIMIDINE DERIVATIVES AS SELECTIVE GROWTH HORMONE SECRECTGOGUE RECEPTOR (GHS-R) ANTAGONISTS | ABBOTT LABORATORIES (US) | 2005-04-07 | — | — | WO | disclosed |
| US-20050070712-A1 | Pyrimidine derivatives as ghrelin receptor modulators | ABBOTT LABORATORIES | 2005-03-31 | — | — | US | disclosed |
| US-4735711-A | ORGANIC MONOSULFIDE | THE DOW CHEMICAL COMPANY (US) | 1988-04-05 | — | — | US | disclosed |
| US-4702822-A | ORGANIC SULFIDE WITH ALKYL THIOCARBONATE, THIONACARBAMATEA, OR THIOPHOSPHATE | THE DOW CHEMICAL COMPANY (US) | 1987-10-27 | — | — | US | disclosed |
| US-4676890-A | MIXTURE OF THIOALKYL AMINE AND HYDROCARBYL SULFIDES; SULFIDE ORES; PREFERENTIAL | THE DOW CHEMICAL COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| WO-1987003222-A1 | COLLECTOR COMPOSITIONS FOR THE FROTH FLOTATION OF MINERAL VALUES | THE DOW CHEMICAL COMPANY (US) | 1987-06-04 | — | — | WO | disclosed |
| WO-1987000451-A1 | NOVEL COLLECTOR COMPOSITION FOR FROTH FLOTATION | THE DOW CHEMICAL COMPANY (US) | 1987-01-29 | — | — | WO | disclosed |
| WO-1986006983-A1 | NOVEL COLLECTORS FOR THE SELECTIVE FROTH FLOTATION OF SULFIDE MINERALS | THE DOW CHEMICAL COMPANY (US) | 1986-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171131-A1 | Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists | GHSR, GIPR, GPR119 | ACHE 4597/4885SLC2A1 151/4885ALDH1A1 2435/4885 |
| US-20050171132-A1 | Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists | GHSR, GIPR, GPR119 | ACHE 4665/4885SLC2A1 128/4885ALDH1A1 3084/4885 |
| US-20050070712-A1 | Pyrimidine derivatives as ghrelin receptor modulators | GPR119, GIPR, GCGR | ACHE 4530/4885SLC2A1 297/4885ALDH1A1 2333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.